The smoothened (SMO) receptor, a key signal transducer in the hedgehog signalling pathway, is responsible for the maintenance of normal embryonic development and is implicated in carcinogenesis. It is classified as a class frizzled (class F) G-protein-coupled receptor (GPCR), although the canonical hedgehog signalling pathway involves the GLI transcription factors and the sequence similarity with class A GPCRs is less than 10%. Here we report the crystal structure of the transmembrane domain of the human SMO receptor bound to the small-molecule antagonist LY2940680 at 2.5 Å resolution. Although the SMO receptor shares the seven-transmembrane helical fold, most of the conserved motifs for class A GPCRs are absent, and the structure reveals an unusually complex arrangement of long extracellular loops stabilized by four disulphide bonds. The ligand binds at the extracellular end of the seventransmembrane-helix bundle and forms extensive contacts with the loops.
The smoothened (SMO) receptor, a key signal transducer in the hedgehog signalling pathway, is responsible for the maintenance of normal embryonic development and is implicated in carcinogenesis. It is classified as a class frizzled (class F) G-protein-coupled receptor (GPCR), although the canonical hedgehog signalling pathway involves the GLI transcription factors and the sequence similarity with class A GPCRs is less than 10%. Here we report the crystal structure of the transmembrane domain of the human SMO receptor bound to the small-molecule antagonist LY2940680 at 2.5 Å resolution. Although the SMO receptor shares the seven-transmembrane helical fold, most of the conserved motifs for class A GPCRs are absent, and the structure reveals an unusually complex arrangement of long extracellular loops stabilized by four disulphide bonds. The ligand binds at the extracellular end of the seventransmembrane-helix bundle and forms extensive contacts with the loops.
The SMO receptor is an essential component of the canonical hedgehog signalling pathway, which has a key role in the regulation of embryonic development in animals 1, 2 . In vertebrates, the binding of hedgehog signalling proteins to the receptor patched 3, 4 , a 12-transmembrane protein that inhibits the activity of the SMO receptor 5 , results in translocation of the SMO receptor into cilia 6 . In cilia, the activated SMO receptor induces the modification of GLI transcription factors into the active form, thereby inhibiting the processing of GLI transcription factors into a repressor form. Subsequently, active GLI transcription factors translocate to the nucleus activating the transcription of GLI-targeted genes that control embryonic development and other processes 2 
.
The SMO receptor shows a high sequence similarity to the frizzled (FZD) receptors, which mediate the WNT signalling pathway 7, 8 . Both SMO and FZD receptors contain an extracellular domain (ECD) composed of an extracellular cysteine-rich domain (CRD) and an ECD linker domain ( Supplementary Fig. 1 ), a seven-transmembrane helical (7TM) domain and an intracellular carboxy-terminal domain 9 . The CRD of the FZD receptors binds the endogenous lipoglycoprotein ligands, the WNTs 10, 11 ; unfortunately, the function of the homologous SMO receptor CRD remains unclear. The 7TM domains of SMO and FZD receptors are reminiscent of class A GPCRs 12 although their sequences are distinct from other GPCRs, sharing less than 10% sequence identity. For this reason and because of their distinct signalling properties, the SMO and FZD receptors have been defined as class F 9, 13 . The classification of the SMO receptor as a GPCR remains controversial, principally owing to the lack of GPCR-like features in the canonical hedgehog signalling pathway, although emerging evidence indicates that the SMO receptor can share some functional similarities with other classical GPCRs 14 . For example, activated SMO receptor can be phosphorylated by a GPCR kinase, leading to b-arrestin translocation and binding 15 . Moreover, the SMO receptor can couple to G proteins, particularly G i 16 , which inhibits cAMP production, controlling cell migration 17 . Finally, the function of the SMO receptor can be modulated by natural and synthetic small-molecule agonists and antagonists, some of which are potential antitumour agents 18 .
Structure of the SMO receptor 7TM domain
An engineered construct of the human SMO receptor with a thermostabilized apocytochrome b 562 RIL (BRIL) fused to the amino terminus of S190 and the C terminus truncated at Q555, which preserved the ligand-binding property of wild-type human SMO receptor, was expressed, purified and crystallized in complex with the antagonist LY2940680 (refs 19, 20) using a lipidic mesophase method 21 (Supplementary Figs 2-4). The structure was solved using a 3.5 Å single-wavelength anomalous dispersion (SAD) data set, followed by extending the resolution to 2.5 Å using native data collected from five crystals (Supplementary Table 1 ).
The SMO receptor structure ( Fig. 1 ) reveals a canonical GPCR 7TM bundle fold with a short helix VIII packed parallel to the membrane bilayer. The ECD linker domain and long extracellular loops (ECLs) form intricate structures stabilized by four disulphide bonds: C193-C213, C217-C295, C314-C390 and C490-C507. The ligand LY2940680 binds in a pocket at the extracellular side of the receptor formed by the 7TM bundle and the ECLs. The receptor crystallizes as a parallel dimer in the crystallographic asymmetric unit ( Fig. 1 and Supplementary Fig. 5 ) with the interface involving helices IV and V, as observed for CXCR4 (ref. 22) . It has been reported that the SMO receptor forms a functionally important dimer, although it is unclear whether the crystallographic dimer is the same as that found in the cell membrane 23 . Because the difference between the two protomers is small ( Supplementary Fig. 5 ), we will focus on molecule A in the following discussion for brevity, except where otherwise noted.
7TM comparisons with class A GPCRs
Sequence similarity between the SMO receptor and class A GPCRs is very low (less than 10% sequence identity), and SMO and other class F receptors lack most of the conserved class A motifs, including D[E]R 3.50 Y in helix III, CWXP 6 .50 in helix V and NP 7.50 XXY in helix VII 12 (superscript numbers reflect the B&W numbering system for GPCRs 24 , brackets define an alternative residue and X denotes any residue). However, an overlay of the SMO receptor structure with previously solved class A GPCR structures shows relatively high spatial conservation of the 7TM bundle (Fig. 2a, b and Supplementary Fig. 6 ). Several intracellular structural features of class A GPCR 7TM bundles are also preserved, including a helical turn in short intracellular loop 1 (ICL1) and a short intracellular helix VIII running parallel to the membrane surface, although it has an interface (residues T541, I544 and W545) with helix I (residues T251 and A254) (Fig. 2c ) that is distinct from the interface observed in class A GPCRs 12 . Structural similarity with class A GPCRs makes transplanting the B&W numbering 24 system to class F receptors possible on the basis of structural superposition. In each helix, the following residues are assigned number 50: T245 Figs 1, 2 and 6 ). The numbering of the other residues in each helix is counted relative to the X.50 position according to the B&W numbering system 24 . Despite the overall structural conservation, the 7TM fold of the SMO receptor has many distinct features. For example, when compared with class A GPCRs the extracellular tip of helix V is shifted towards the ligand-binding cavity. Most importantly helices V, VI and VII of the SMO receptor lack the most conserved prolines (P 5.50 , P 6.50 and P 7.50 ), which have pivotal roles in the activation process of class A GPCRs 12 .
In the b 2 adrenergic receptor, P 5.50 has been shown to act as a local trigger of GPCR activation along with I 3.40 and F 6.44 (ref. 25) . Instead of P 5.50 in helix V of class A GPCRs, the SMO receptor has P407 5.46 in an adjacent helical turn (Fig. 2d) . In helix VI, P 6.50 induces a kink in class A GPCRs, which facilitates the large movement of the intracellular segment of helix VI during activation. The SMO receptor has no proline in helix VI, and thus this helix is straighter than in class A GPCRs (Fig. 2e) . Similarly, in helix VII, which typically has the conserved NPXXY motif in class A GPCRs, the proline is also absent (Fig. 2f ). Although these prolines are missing in the SMO receptor, we observed a large number of glycines in helices V, VI and VII ( Supplementary Fig. 2 ). Conceivably, these glycines could facilitate both flexibility and bending of the helices, thereby enabling 7TM packing and conformational changes during the activation of the SMO receptor. In the current structure of the SMO receptor in complex with an antagonist, helix VI is found in an inactive-like, closed state ( Supplementary Fig. 7 ), presumably precluding G-protein binding.
Binding site of LY2940680
LY2940680 is a SMO receptor antagonist designed for the treatment of solid tumours 19 . The SMO receptor binding pocket has a long and narrow shape and is connected to the extracellular aqueous environment through a small opening formed by the ECD linker domain, ECL2 and ECL3 (Fig. 3a) . This orifice probably facilitates small-molecule ligand entry into the 7TM core region. Residues from the extracellular tips of helices I, II, V, and VII interact with LY2940680, most notably R400 5.39 of helix V, which hydrogen bonds with the phthalazine ring system of the ligand. Most of the other contact residues belong to the ECD linker domain and ECLs (Fig. 3b, c and Supplementary Fig. 8 ). Several structured water molecules are identified in the ligand pocket, including two waters mediating the hydrogen-bonding network between R400 Fig. 9 ). Although these waters do not directly contact LY2940680, they may have an important role in the conformational properties and dynamics of the pocket. Mutation of D473 6.55 -which participates in this watermediated hydrogen-bonding network-to histidine results in resistance to the approved Genentech drug GDC-0449 (ref. 26) . Direct contact of this residue with LY2940680 is limited (distance between the carboxylate of D473
6.55 and LY2940680 is 4.04 Å in molecule A and 4.31 Å in molecule B). Cyclopamine, a naturally occurring steroid and the first identified small-molecule SMO receptor ligand, inhibits the hedgehog signalling pathway 27 . Radioligand assays revealed that LY2940680 and the SMO receptor agonist SAG compete with the binding of 3 H-cyclopamine ( Supplementary Fig. 3 ), indicating that these ligands bind within the long and narrow cavity embedded in the 7TM domain of the SMO receptor.
ECD linker domain and ECL structures
The SMO receptor has a unique ECD linker domain, and its ECLs are long compared to most class A GPCRs. These extracellular domains 
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are organized into complex tertiary structures through covalent and noncovalent interactions forming a lid on the 7TM bundle (Fig. 4a, b) . The unusually long ECL1 (Fig. 4c) is connected to the ECD linker domain through a disulphide bond between C217 and C295, which divides ECL1 into two distinctive segments. Preceding C295, there is a short a-helical structure (G288 to V294) stabilized by cation-p interactions between the guanidinium group of R290 and the imidazole group of H231 1.36 from helix I. After C295, ECL1 is packed into a U-shaped loop that is stabilized by an ionic interaction between R302 and E305. In addition, this loop segment forms contacts with the ECD linker domain through a hydrogen-bonding network involving residues N202, S205, D298 and T300. ECL2 forms a b-hairpin and connects to helix III by a disulphide bond between C314 3.25 and C390. This loop is positioned deep within the cavity formed by the 7TM bundle and makes extensive contacts with LY2940680. ECL3 is the longest loop of the SMO receptor and forms a protrusion from the 7TM bundle into the extracellular space (Fig. 4d) . The long extension of helix VI adopts a well-ordered a-helical structure that is partially stabilized by an ionic interaction between E479 and R482. This a-helical extension connects to helix VI through a 45u non-proline kink that is stabilized by several water molecules (Supplementary Fig. 10 ). On top of the ECL3 helical structure there is C490, which forms a disulphide bond with C507. The loop between C490 and C507 is mostly disordered, whereas the segment between C507 and the extracellular tip of helix VII forms an extended strand. ECL3 also makes contact with the ECD linker domain: R485 interacts with E208 within the ECD linker domain through a salt bridge; the amide side chain of Q491 and the guanidinium group of R512 form hydrogen bonds with the main-chain carbonyl groups of V195 and L221, respectively. The integrity of the ECL structures is essential for maintaining the SMO receptor in an inactive state, as disruption of the extracellular structures by mutations of the extracellular cysteines increases SMO receptor activity 28 .
In the extracellular region, the only structural feature that the SMO receptor shares with class A GPCRs is the b-hairpin structure of ECL2 that is linked to the extracellular tip of helix III through a disulphide bond (Fig. 5) . The corresponding cysteine in position 3.25 (B&W numbering 24 ) , is conserved in nearly all class A and other GPCRs. The b-hairpin structure of ECL2 appears to be a hallmark of class A peptide-binding GPCRs 22, [29] [30] [31] [32] [33] [34] , which has been shown by docking studies 31 and peptide-receptor co-crystal structures 22, 32 to have an important role in the recognition of peptide ligands. The ECL2s of peptide-binding receptors all point outwards from the 7TM core domain, leaving relatively open and spacious binding cavities for their cognate peptide ligands (Fig. 5c-f) . By contrast, the b-hairpin structure of ECL2 in rhodopsin folds on top of its covalently attached ligand retinal, sealing the extracellular entrance of the pocket (Fig. 5b) . Interestingly, the ECL2 structure of the SMO receptor is distinct from both rhodopsin and peptide-binding GPCRs. Although ECL2 sits much deeper in the SMO receptor than in class A peptide receptors and occupies a substantial space in the cavity of 7TM bundle (Fig. 5a) , unlike in rhodopsin, the b-hairpin in the SMO receptor does not occlude the ligand entrance. Instead, the ECL2 of the SMO receptor is positioned laterally to LY2940680 ( Supplementary Fig. 11 ), forming a large part of the binding pocket for this ligand.
Homology with frizzled family receptors
Within class F receptors, one can find a gapless alignment at transmembrane helices ( Supplementary Fig. 1 ), and 45 residues are fully conserved within the ECD linker and 7TM domains (Fig. 6a, b) . The cysteines that form disulphide bonds maintaining the structures of the ECD linker domain and the ECLs in the SMO receptor are highlỹ RESEARCH ARTICLE preserved in the FZD receptors (the only exception is FZD4, in which the disulphide bond in ECL3 is missing, probably owing to a very short loop), indicating the importance of disulphide bonds in maintaining the ECL structures for the FZD receptors. In the extracellular half of the 7TM bundle, the conserved residues form a cluster of hydrophobic side chains buried between helices III (F318 3.29 , Y322 3.33 , M326 3.37 ), V (F403 5.42 , V404 5.43 , P407 5.46 ) and ECL2 (V392), which is apparently important for the structural integrity of these receptors. Closer to the intracellular membrane boundary, there is an unusually high number of conserved tryptophans: W331 35 . In the FZD receptors, the KTXXXW motif in helix VIII is highly conserved and has been shown to be critical for the activation of the WNT/b-catenin signalling pathway by interacting directly with disheveled 36, 37 . Sequence alignment shows that the SMO receptor has an extra alanine between lysine and threonine, but that the rest of the motif is conserved. In the SMO receptor structure, this motif stabilizes the a-helical structure of helix VIII, which packs parallel to the membrane (Fig. 6c) . The hydroxyl group of the conserved 
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T541 of this motif forms a hydrogen bond with the main-chain carbonyl group of V536 at the intracellular end of helix VII, whereas the indole nitrogen of W545 forms a hydrogen-bond interaction with the hydroxyl group of T251 1.56 , which is conserved in the FZD receptors. The a-helical structure of helix VIII therefore probably has a critical role for the interaction of activated FZD receptors with downstream signalling proteins, such as disheveled.
Conclusion
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RESEARCH ARTICLE most fundamental physiological processes for multicellular metazoan. The SMO receptor structure highlights the incredible use of the 7TM structural fold, with little sequence similarity to other GPCR classes, and is a great example of structural conservation in protein space. As we learn more about different GPCR classes and their structurefunction relationships, including the expansion of many different intracellular interacting partners beyond G proteins, it is probable that the term 'GPCR' may be of limited value in describing the incredible power of the 7TM fold 39 in biology.
METHODS SUMMARY
The BRIL-DCRD-SMO-DC construct for structural study was expressed in Spodoptera frugiperda (Sf9) cells. Ligand-binding and functional assays were performed as described in Methods. Sf9 cell membranes were solubilized using 1% (w/v) n-dodecyl-b-D-maltopyranoside and 0.2% (w/v) cholesteryl hemisuccinate, and purified by immobilized metal ion affinity chromatography (IMAC), followed by reverse IMAC after cleaving N-terminal Flag-103His tags by Histagged tobacco etch virus protease. The purified protein at a concentration of 50-60 mg ml 21 was mixed with monoolein and cholesterol in a ratio of 40%:54%:6% (w/w/w) to form lipidic cubic phase (LCP), from which the receptor was crystallized. Crystals were grown at 20 uC in 40 nl protein-laden LCP boluses overlaid by 800 nl of precipitant solutions as described in Methods. Crystals were collected from the LCP matrix and flash frozen in liquid nitrogen. X-ray diffraction data were collected on the 23ID-D beamline at the Advanced Photon Source using a 20 mm minibeam at a wavelength of 1.0330 Å . Phase information was obtained by SAD data obtained from a single crystal soaked in tantalum bromide. Data collection, processing, structure solution and refinement are described in Methods.
Full Methods and any associated references are available in the online version of the paper.
